A team from the International Education College of Zhejiang Chinese Medical University, Hangzhou, China, has conducted a review of systematic reviews and meta-analysis studies around the topic of nutrition in disease.
Researchers at the University of Arizona College of Medicine–Tucson, along with collaborators at Harvard University, harnessed the power of artificial intelligence to identify causes of Alzheimer's disease and potential ...
May 16, 2023
0
129
Fresh insights into the spread of damaging proteins that build up in the brains of people with Alzheimer's disease could hold the key to stopping the condition from progressing, a study says.
May 15, 2023
0
84
Researchers are striving to make earlier diagnosis of Alzheimer's dementia possible with a machine learning (ML) model that could one day be turned into a simple screening tool anyone with a smartphone could use.
May 15, 2023
0
14
A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.
May 12, 2023
0
27
Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting tens of millions of people worldwide, and it is the most common cause of dementia. Early-onset AD is typically associated with mutations in the ...
May 12, 2023
0
56
Researchers from the University of California, Irvine have found that exposure to traffic-related air pollution in Irvine led to memory loss and cognitive decline and triggered neurological pathways associated with the onset ...
May 11, 2023
0
11
People who have sleep apnea and spend less time in deep sleep may be more likely to have brain biomarkers that have been linked to an increased risk of stroke, Alzheimer's disease and cognitive decline, according to new research ...
May 10, 2023
0
43
The early detection and treatment of dementia such as Alzheimer's is still one of the great challenges of modern medicine. It is already known that certain proteins in the cerebrospinal fluid can be used to diagnose Alzheimer's ...
May 9, 2023
0
112
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...
May 3, 2023
0
129
